Assessment of Familial Risk in Patients with Hidradenitis Suppurativa

Raquel L. Bruinsma,Kristen Fajgenbaum,Yuhong Yang,M. Mar Melendez‐Gonzalez,Karen L. Mohlke,Yun Li,Christopher J. Sayed

DOI: https://doi.org/10.1111/bjd.19664

2021-01-01

Abstract:Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder resulting in recurrent, painful nodules, abscesses, and sinuses with predilection for intertriginous sites.1 In previous cohorts relying primarily on chart review, 30-40% of patients reported family history of disease,2 but familial risk has not been formally assessed with more meticulous and focused data collection. 676 HS patients at the University of North Carolina Chapel Hill were enrolled in our clinical registry from August 2018-December 2019, which collected detailed family history data using questionnaires and skilled interviewers. 57.5% of patients reported HS in either first- or second-degree relatives, including 49.5% with an affected first-degree relative. This suggests a possible genetic contribution to HS. This study's aim was to quantify familial risk in patients with HS.